Abstract
The small leucine rich proteoglycans (SLRPs), structurally consisting of protein cores and various glycosaminoglycan side chains, are grouped into five classes based on common structural and functional properties. Besides being an important structural component of extracellular matrix (ECM), SLRPs have been implicated in the complex network of signal transduction and host immune responses. The focus of this review is on SLRPs in host immunity. Because host immunity plays an important part in the pathogenesis of renal diseases, the role of SLRPs in this set of diseases will also be discussed.
Similar content being viewed by others
Abbreviations
- SLRP:
-
Small leucine rich proteoglycans
- ECM:
-
Extracellular matrix
- LRR:
-
Leucine rich repeat
- PAMP:
-
Pathogen associated molecular pattern
- DAMP:
-
Danger associated molecular pattern
- HIF-2 α:
-
Hypoxia-inducible factor 2α
- SLE:
-
Systemic lupus erythematosus
- RANTES:
-
Regulated upon activation, normal T cell expressed and secreted
- MyD88:
-
Myeloid differentiation factor 88
- TRIF β:
-
TIR-domain-containing adaptor-inducing interferon β
- TLR:
-
Toll-like receptor
- TNF α:
-
Tumor necrosis factor α
- MIP:
-
Macrophage inflammatory protein
- NLRP3:
-
NLR family, pyrin domain containing 3
- NOX:
-
NADPH oxidases
- ROS:
-
Reactive oxygen species
- TGF:
-
Transforming growth factor
- miR:
-
Micro-RNA
- PDCD:
-
Programmed cell death protein
- MCP-1:
-
Monocyte chemoattractant protein-1
References
Al Haj Zen A, Lafont A, Durand E, Brasselet C, Lemarchand P, Godeau G et al (2003) Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts. Matrix Biol 22:251–258
Albig AR, Roy TG, Becenti DJ, Schiemann WP (2007) Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis. Angiogenesis 10:197–216
Anders HJ, Schaefer L (2014) Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol 25:1387–1400
Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF et al (2009) Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 284:24035–24048
Bedke J, Kiss E, Schaefer L, Behnes CL, Bonrouhi M, Gretz N et al (2007) Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 7:527–537
Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD et al (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360:361–364
Brunskill EW, Potter SS (2012) Changes in the gene expression programs of renal mesangial cells during diabetic nephropathy. BMC Nephrol 13:70
Carlson EC, Lin M, Liu CY, Kao WW, Perez VL, Pearlman E (2007) Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysaccharide-induced keratitis by direct interaction with CXCL1. J Biol Chem 282:35502–35509
Chen J, Wong-Chong J, SundarRaj N (2011) FGF-2- and TGF-beta1-induced downregulation of lumican and keratocan in activated corneal keratocytes by JNK signaling pathway. Invest Ophthalmol Vis Sci 52:8957–8964
Christensen G, Herum KM, Lunde IG (2018) Sweet, yet underappreciated: Proteoglycans and extracellular matrix remodeling in heart disease. Matrix Biol. https://doi.org/10.1016/j.matbio.2018.01.001
Costacurta A, Priante G, D'Angelo A, Chieco-Bianchi L, Cantaro S (2002) Decorin transfection in human mesangial cells downregulates genes playing a role in the progression of fibrosis. J Clin Lab Anal 16:178–186
Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136:729–743
De Cosmo S, Tassi V, Thomas S, Piras GP, Trevisan R, Cavallo Perin P et al (2002) The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes. Nephron 92:72–76
De Felice M, Esposito L, Pucci B, Carpentieri F, De Falco M, Rossi M et al (2003) Biochemical characterization of a CDC6-like protein from the crenarchaeon Sulfolobus solfataricus. J Biol Chem 278:46424–46431
De Heer E, Sijpkens YW, Verkade M, den Dulk M, Langers A, Schutrups J et al (2000) Morphometry of interstitial fibrosis. Nephrol Dial Transplant 15(Suppl 6):72–73
Dellett M, Hu W, Papadaki V, Ohnuma S (2012) Small leucine rich proteoglycan family regulates multiple signalling pathways in neural development and maintenance. Develop Growth Differ 54:327–340
Diamond JR, Levinson M, Kreisberg R, Ricardo SD (1997) Increased expression of decorin in experimental hydronephrosis. Kidney Int 51:1133–1139
Ebefors K, Granqvist A, Ingelsten M, Molne J, Haraldsson B, Nystrom J (2011) Role of glomerular proteoglycans in IgA nephropathy. PLoS One 6:e18575
Frey H, Schroeder N, Manon-Jensen T, Iozzo RV, Schaefer L (2013) Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J 280:2165–2179
Frey H, Moreth K, Hsieh LT, Zeng-Brouwers J, Rathkolb B, Fuchs H et al (2017) A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia. Glycoconj J 34:393–404
Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM et al (2013) Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS One 8:e58014
Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ et al (2009) Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol 185:743–754
Gubbiotti MA, Neill T, Frey H, Schaefer L, Iozzo RV (2015) Decorin is an autophagy-inducible proteoglycan and is required for proper in vivo autophagy. Matrix Biol 48:14–25
Hayashi Y, Call MK, Chikama T, Liu H, Carlson EC, Sun Y et al (2010) Lumican is required for neutrophil extravasation following corneal injury and wound healing. J Cell Sci 123:2987–2995
Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA et al (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302(Pt 2):527–534
Hsieh LT, Nastase MV, Roedig H, Zeng-Brouwers J, Poluzzi C, Schwalm S, et al (2017) Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants. Int J Mol Sci. https://doi.org/10.3390/ijms18030595
Huijun W, Long C, Zhigang Z, Feng J, Muyi G (2005) Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis. Exp Mol Pathol 78:17–24
Hutter R, Huang L, Speidl WS, Giannarelli C, Trubin P, Bauriedel G et al (2013) Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma. Circulation 128:2351–2363
Iozzo MAGaRV (2015) Proteoglycans regulate autophagy via outside-in signaling: An emerging new concept. Matrix Biol 48:6–13
Iozzo RV, Schaefer L (2015) Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol 42:11–55
Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA et al (1996) Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2:418–423
Kalamajski S, Oldberg A (2009) Homologous sequence in lumican and fibromodulin leucine-rich repeat 5-7 competes for collagen binding. J Biol Chem 284:534–539
Karamanos NK (2017) Matrix pathobiology-central roles for proteoglycans and heparanase in health and disease. FEBS J 284:7–9
Keene DR, San Antonio JD, Mayne R, McQuillan DJ, Sarris G, Santoro SA et al (2000) Decorin binds near the C terminus of type I collagen. J Biol Chem 275:21801–21804
Kikuchi A, Tomoyasu H, Kido I, Takahashi K, Tanaka A, Nonaka I et al (2000) Haemopoietic biglycan produced by brain cells stimulates growth of microglial cells. J Neuroimmunol 106:78–86
Kiss E, Popovic ZV, Bedke J, Adams J, Bonrouhi M, Babelova A et al (2010) Peroxisome proliferator-activated receptor (PPAR) gamma can inhibit chronic renal allograft damage. Am J Pathol 176:2150–2162
Kitaya K, Yasuo T (2009) Dermatan sulfate proteoglycan biglycan as a potential selectin L/CD44 ligand involved in selective recruitment of peripheral blood CD16(-) natural killer cells into human endometrium. J Leukoc Biol 85:391–400
Kou I, Nakajima M, Ikegawa S (2010) Binding characteristics of the osteoarthritis-associated protein asporin. J Bone Miner Metab 28:395–402
Kresse H, Liszio C, Schonherr E, Fisher LW (1997) Critical role of glutamate in a central leucine-rich repeat of decorin for interaction with type I collagen. J Biol Chem 272:18404–18410
Kuriyama S, Lupo G, Ohta K, Ohnuma S, Harris WA, Tanaka H (2006) Tsukushi controls ectodermal patterning and neural crest specification in Xenopus by direct regulation of BMP4 and X-delta-1 activity. Development 133:75–88
Kuroda M, Sasamura H, Kobayashi E, Shimizu-Hirota R, Nakazato Y, Hayashi M et al (2004) Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease. Clin Nephrol 61:7–16
Lohr K, Sardana H, Lee S, Wu F, Huso DL, Hamad AR et al (2012) Extracellular matrix protein lumican regulates inflammation in a mouse model of colitis. Inflamm Bowel Dis 18:143–151
Merline R, Lazaroski S, Babelova A, Tsalastra-Greul W, Pfeilschifter J, Schluter KD et al (2009) Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. J Physiol Pharmacol 60(Suppl 4):5–13
Merline R, Moreth K, Beckmann J, Nastase MV, Zeng-Brouwers J, Tralhao JG et al (2011) Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal 4:ra75
Mogyorosi A, Ziyadeh FN (1998) Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Phys 275:F827–F832
Moreth K, Brodbeck R, Babelova A, Gretz N, Spieker T, Zeng-Brouwers J et al (2010) The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest 120:4251–4272
Moreth K, Iozzo RV, Schaefer L (2012) Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle 11:2084–2091
Moreth K, Frey H, Hubo M, Zeng-Brouwers J, Nastase MV, Hsieh LT et al (2014) Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol 35:143–151
Morris SA, Almeida AD, Tanaka H, Ohta K, Ohnuma S (2007) Tsukushi modulates Xnr2, FGF and BMP signaling: regulation of Xenopus germ layer formation. PLoS One 2:e1004
Moss J, Shore I, Woodrow D (1998) An ultrastructural study of the colocalization of biglycan and decorin with AA amyloid fibrils in human renal glomeruli. Amyloid: The International Journal of Experimental and Clinical Investigation: The Official Journal of the International Society of Amyloidosis 5:43–48
Mozes MM, Bottinger EP, Jacot TA, Kopp JB (1999) Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice. J Am Soc Nephrol 10:271–280
Nastase MV, Young MF, Schaefer L (2012) Biglycan: a multivalent proteoglycan providing structure and signals. J Histochem Cytochem 60:963–975
Nastase MV, Iozzo RV, Schaefer L (2014) Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology. Biochim Biophys Acta 1840:2460–2470
Nastase MV, Janicova A, Roedig H, Hsieh LT, Wygrecka M, Schaefer L (2018) Small leucine-rich proteoglycans in renal inflammation: two sides of the coin. J Histochem Cytochem 66:261–272
Nikitovic D, Chalkiadaki G, Berdiaki A, Aggelidakis J, Katonis P, Karamanos NK et al (2011) Lumican regulates osteosarcoma cell adhesion by modulating TGFbeta2 activity. Int J Biochem Cell Biol 43:928–935
Ohta K, Kuriyama S, Okafuji T, Gejima R, Ohnuma S, Tanaka H (2006) Tsukushi cooperates with VG1 to induce primitive streak and Hensen's node formation in the chick embryo. Development 133:3777–3786
Ohta K, Ito A, Kuriyama S, Lupo G, Kosaka M, Ohnuma S et al (2011) Tsukushi functions as a Wnt signaling inhibitor by competing with Wnt2b for binding to transmembrane protein Frizzled4. Proc Natl Acad Sci U S A 108:14962–14967
Okuda S, Languino LR, Ruoslahti E, Border WA (1990) Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453–462
Pietraszek K, Chatron-Colliet A, Brezillon S, Perreau C, Jakubiak-Augustyn A, Krotkiewski H, et al (2014) Lumican: A new inhibitor of matrix metalloproteinase-14 activity. FEBS Lett 588(23):4319–4324
Popovic ZV, Wang S, Papatriantafyllou M, Kaya Z, Porubsky S, Meisner M et al (2011) The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis. J Immunol 187:6217–6226
Rehn AP, Chalk AM, Wendel M (2006) Differential regulation of osteoadherin (OSAD) by TGF-beta1 and BMP-2. Biochem Biophys Res Commun 349:1057–1064
Rehn AP, Cerny R, Sugars RV, Kaukua N, Wendel M (2008) Osteoadherin is upregulated by mature osteoblasts and enhances their in vitro differentiation and mineralization. Calcif Tissue Int 82:454–464
Ross MD, Bruggeman LA, Hanss B, Sunamoto M, Marras D, Klotman ME et al (2003) Podocan, a novel small leucine-rich repeat protein expressed in the sclerotic glomerular lesion of experimental HIV-associated nephropathy. J Biol Chem 278:33248–33255
Schaefer L (2011) Small leucine-rich proteoglycans in kidney disease. J Am Soc Nephrol 22:1200–1207
Schaefer L, Iozzo RV (2008) Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 283:21305–21309
Schaefer L, Iozzo RV (2012) Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation. Curr Opin Genet Dev 22:56–57
Schaefer L, Hausser H, Altenburger M, Ugorcakova J, August C, Fisher LW et al (1998) Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int 54:1529–1541
Schaefer L, Grone HJ, Raslik I, Robenek H, Ugorcakova J, Budny S et al (2000) Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int 58:1557–1568
Schaefer L, Raslik I, Grone HJ, Schonherr E, Macakova K, Ugorcakova J et al (2001) Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J 15:559–561
Schaefer L, Macakova K, Raslik I, Micegova M, Grone HJ, Schonherr E et al (2002) Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 160:1181–1191
Schaefer L, Mihalik D, Babelova A, Krzyzankova M, Grone HJ, Iozzo RV et al (2004) Regulation of fibrillin-1 by biglycan and decorin is important for tissue preservation in the kidney during pressure-induced injury. Am J Pathol 165:383–396
Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M et al (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115:2223–2233
Schaefer L, Tsalastra W, Babelova A, Baliova M, Minnerup J, Sorokin L et al (2007) Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin. Am J Pathol 170:301–315
Schaefer L, Tredup C, Gubbiotti MA, Iozzo RV (2017) Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology. FEBS J 284:10–26
Shao H, Lee S, Gae-Scott S, Nakata C, Chen S, Hamad AR et al (2012) Extracellular matrix lumican promotes bacterial phagocytosis, and Lum-/- mice show increased Pseudomonas aeruginosa lung infection severity. J Biol Chem 287:35860–35872
Silverstein DM, Travis BR, Thornhill BA, Schurr JS, Kolls JK, Leung JC et al (2003) Altered expression of immune modulator and structural genes in neonatal unilateral ureteral obstruction. Kidney Int 64:25–35
Sjoberg AP, Manderson GA, Morgelin M, Day AJ, Heinegard D, Blom AM (2009) Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol 46:830–839
Stokes MB, Holler S, Cui Y, Hudkins KL, Eitner F, Fogo A et al (2000) Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease. Kidney Int 57:487–498
Stokes MB, Hudkins KL, Zaharia V, Taneda S, Alpers CE (2001) Up-regulation of extracellular matrix proteoglycans and collagen type I in human crescentic glomerulonephritis. Kidney Int 59:532–542
Theocharis AD, Skandalis SS, Tzanakakis GN, Karamanos NK (2010) Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 277:3904–3923
Thompson J, Wilson P, Brandewie K, Taneja D, Schaefer L, Mitchell B et al (2011) Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. Am J Pathol 179:1179–1187
Tomoeda M, Yamada S, Shirai H, Ozawa Y, Yanagita M, Murakami S (2008) PLAP-1/asporin inhibits activation of BMP receptor via its leucine-rich repeat motif. Biochem Biophys Res Commun 371:191–196
Vial C, Gutierrez J, Santander C, Cabrera D, Brandan E (2011) Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity. J Biol Chem 286:24242–24252
Vij N, Roberts L, Joyce S, Chakravarti S (2005) Lumican regulates corneal inflammatory responses by modulating Fas-Fas ligand signaling. Invest Ophthalmol Vis Sci 46:88–95
Vleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA (1995) Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol 44:211–219
Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, Porubsky S et al (2010) Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Dis Model Mech 3:92–103
Wu F, Vij N, Roberts L, Lopez-Briones S, Joyce S, Chakravarti S (2007) A novel role of the lumican core protein in bacterial lipopolysaccharide-induced innate immune response. J Biol Chem 282:26409–26417
Yamaguchi Y, Mann DM, Ruoslahti E (1990) Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346:281–284
Zeng-Brouwers J, Beckmann J, Nastase MV, Iozzo RV, Schaefer L (2014) De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways. Matrix Biol 35:132–142
Acknowledgements
National Natural Science Foundation of China (grant No.: 81660279, 81701629) , Jiangxi Department of Science and Technology (grant No.: 20151BAB205062 ,20161ACB21016, 20171BCB23088 and 20181ACH80002) and by the startup funding for the scholars studying and coming back from abroad from Ministry of Education, P.R.C (grant No.: 2015060020102070).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zou, W., Wan, J., Li, M. et al. Small leucine rich proteoglycans in host immunity and renal diseases. J. Cell Commun. Signal. 13, 463–471 (2019). https://doi.org/10.1007/s12079-018-0489-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-018-0489-8